(Q44825298)

6 December 2017

title

A murine model of type 2 autoimmune hepatitis: Xenoimmunization with human antigens (English)

1 reference

6 December 2017

1 reference

1 reference

1

1 reference

6 December 2017

Idriss Djilali-Saiah

2

1 reference

6 December 2017

Susana Vitozzi

series ordinal

3

1 reference

6 December 2017

Fernando Alvarez

series ordinal

4

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

6 December 2017

1 reference

6 December 2017

volume

39

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

1066-1074

1 reference

Break of T cell ignorance to a viral antigen in the liver induces hepatitis

6 December 2017

cites work

1 reference

DNA vaccination breaks tolerance for a neo-self antigen in liver: a transgenic murine model of autoimmune hepatitis

21 January 2018

1 reference

Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice

21 January 2018

1 reference

Genetic regulation of autoimmune disease: BALB/c background TGF-beta 1-deficient mice develop necroinflammatory IFN-gamma-dependent hepatitis

21 January 2018

1 reference

The cellular infiltrate in the liver in auto-immune chronic active hepatitis: analysis with monoclonal antibodies

21 January 2018

1 reference

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

21 January 2018

1 reference

7 January 2021

Antibody to liver cytosol (anti-LC1) in patients with autoimmune chronic active hepatitis type 2

1 reference

7 January 2021

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

7 January 2021

Autoimmune hepatitis associated with anti-actin antibodies in children and adolescents

1 reference

7 January 2021

Formiminotransferase cyclodeaminase is an organ-specific autoantigen recognized by sera of patients with autoimmune hepatitis

1 reference

7 January 2021

Anti-liver kidney microsome antibody recognizes a cytochrome P450 from the IID subfamily

1 reference

7 January 2021

Liver/kidney microsomal antibody type 1 and liver cytosol antibody type 1 concentrations in type 2 autoimmune hepatitis

1 reference

7 January 2021

Experimental autoimmune hepatitis: disease induction, time course and T-cell reactivity

1 reference

7 January 2021

Chronic active hepatitis in transgenic mice expressing interferon-gamma in the liver

1 reference

7 January 2021

Synergistic effect of a combined DNA and peptide vaccine against gp100 in a malignant melanoma mouse model

1 reference

7 January 2021

Immunization of naive BALB/c mice with human beta2-glycoprotein I breaks tolerance to the murine molecule

1 reference

7 January 2021

Immunization of mice with human 60-kd Ro peptides results in epitope spreading if the peptides are highly homologous between human and mouse

1 reference

7 January 2021

Induction of autoimmunity by immunization of mice with human thyrotropin receptor

1 reference

7 January 2021

Intranasal or oral immunization of inbred and outbred mice with murine or human rotavirus VP6 proteins protects against viral shedding after challenge with murine rotaviruses.

1 reference

7 January 2021

Genetic immunization of mice with human tyrosinase-related protein 2: implications for the immunotherapy of melanoma

1 reference

7 January 2021

Cytotoxic activity toward mouse melanoma following immunization of mice with transfected cells expressing a human melanoma-associated antigen

1 reference

7 January 2021

IL-12 plasmid-enhanced DNA vaccination against carcinoembryonic antigen (CEA) studied in immune-gene knockout mice

1 reference

7 January 2021

Autoantibody detection in type 2 autoimmune hepatitis using a chimera recombinant protein

1 reference

7 January 2021

Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis

1 reference

7 January 2021

Cytochrome P450IID6 recognized by LKM1 antibody is not exposed on the surface of hepatocytes

1 reference

7 January 2021

Direct ex vivo kinetic and phenotypic analyses of CD8(+) T-cell responses induced by DNA immunization

1 reference

7 January 2021

Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction

1 reference

7 January 2021

A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge

1 reference

7 January 2021

Regulation of T-helper-1 versus T-helper-2 activity and enhancement of tumor immunity by combined DNA-based vaccination and nonviral cytokine gene transfer

1 reference

7 January 2021

Cytokines induce the development of functionally heterogeneous T helper cell subsets

1 reference

7 January 2021

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

1 reference

7 January 2021

Immunohistochemical features of the portal tract mononuclear cell infiltrate in chronic aggressive hepatitis

1 reference

7 January 2021

Autoreactive CD4+ LKM-specific and anticlonotypic T-cell responses in LKM-1 antibody-positive autoimmune hepatitis

1 reference

7 January 2021

Cloning and characterization of human FTCD on 21q22.3, a candidate gene for glutamate formiminotransferase deficiency

1 reference

7 January 2021

Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR.

1 reference

7 January 2021

1 reference

7 January 2021

Identifiers

DOI

10.1002/HEP.20109

1 reference

6 December 2017

1 reference